P621-0093 Screening compound: 2-[4-(2-fluorophenyl)piperazine-1-carbonyl]-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

P621-0093 Screening compound: 2-[4-(2-fluorophenyl)piperazine-1-carbonyl]-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one
P621-0093 Screening compound: 2-[4-(2-fluorophenyl)piperazine-1-carbonyl]-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one alternative view

Chemical Structure Depiction of ChemDiv screening compound P621-0093
2-[4-(2-fluorophenyl)piperazine-1-carbonyl]-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P621-0093

Molecular Formula

C19H19FN4O3 (C19 H19 FN4 O3)

Compound Name

2-[4-(2-fluorophenyl)piperazine-1-carbonyl]-2-methyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one

IUPAC name

2-[4-(2-fluorophenyl)piperazine-1-carbonyl]-2-methyl-2H3H4H-pyrido[32-b][14]oxazin-3-one

SMILES

CC(C(N(CC1)CCN1c(cccc1)c1F)=O)(C(N1)=O)Oc2c1nccc2

InChI

InChI=1S/C19H19FN4O3/c1-19(17(25)22-16-15(27-19)7-4-8-21-16)18(26)24-11-9-23(10-12-24)14-6-3-2-5-13(14)20/h2-8H,9-12H2,1H3,(H,21,22,25)/t19-/m1/s1

InChI Key

DFPLQINZDJKMBA-LJQANCHMSA-N

MDL Number (MFCD)

MFCD28120901

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

370.38

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.125

Distribution Coefficient, logD

2.123

Water Solubility, LogSw

-2.79

Polar Surface Area

61.327

Acid Dissociation Constant (pKa)

9.72

Base Dissociation Constant (pKb)

2.94

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

31.60

P621-0093 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Inflammatory Library (24602 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Cyclic compounds
Agro:
  • Agro

References: we are preparing a list of scientific research reports with P621-0093 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P621-0093?
Check Price and Availability of P621-0093, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P621-0093 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P621-0093
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P621-0093
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P621-0093 available by request